In a period of pandemics like this, international health organizations, states and citizens are keeping an eye on the coronavirus vaccine, which is being developed by several companies. But what is Europe's approach to the vaccine?
Moderna vaccine
The European Union has agreed on 160 million preliminary doses of the Moderna vaccine in talks with the company, which could be finalized soon, a spokesman for the health commissioner said on Tuesday. "In the context of finalizing the talks we agreed on 160 million doses," spokesman Stefan De Keersmaecker told the European Commission 's daily press conference. That could be 80 million doses plus an opportunity to ask for an additional 80 million doses. ”
"Of course we continue to have negotiations and we will see how this will translate into an actual contract," he added. The talks took place after the American biotechnology company Moderna announced that its vaccine appears to be 94.5% effective.
BioNTech and Pfizer vaccine
The EU will sign an agreement to provide up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer. Ursula von der Leyen, president of the EU Commission, said the deal would be authorized on Wednesday. This comes after the announcement by the two companies that their experimental vaccine was more than 90% effective. It is hoped that the vaccine will be ready to be distributed within a few weeks after final clinical trials are completed and regulatory approval is obtained.
Agreement with CureVac
The EU has concluded numerous contracts for vaccines, including one announced Monday with CureVac, a European company that is also working.
Agreement with AstraZeneca
Në fund të gushtit, BE njoftoi se ka negociuar në emër të shteteve anëtare të BE-së me kompaninë farmaceutike AstraZeneca për blerjen e një vaksine kundër Covid-19, e cila po zhvillohet në bashkëpunim me Universitetin e Oksfordit. Vaksina do të jepet te vendet anëtare si edhe do të dhurohet te vendet me të ardhura të ulëta dhe të mesme si edhe vendeve të tjera të Europës.
Shqipëria dhe vaksinimi
“Një iniciativë është iniciativa botërore e COVAX, një iniciativë e shumë vendeve dhe shumë partnerëve të rëndësishëm ndërkombëtarë në fushën e vaksinimit nën udhëheqjen e OBSH. Ne do të zgjedhim atë vaksinë që është efikase dhe e sigurt”, u shpreh në gusht Silva Bino nga Instituti i Shëndetit Publik. Shqipëria do ta sigurojë vaksinën kundër Covid-19 përmes OBSH-së dhe është në bisedime me shtete të tjera.
In a meeting organized with experts of the immunization committee at the Institute of Public Health, at the end of September, the Minister of Health and Social Protection, Ogerta Manastirliu, said that Albania will have the right to choose the safest vaccine, engaging financially in an international mechanism, like over 80 other countries around the world, including European Union countries.
"Based on your valid recommendations, the Council of Ministers has approved the signing of an engagement agreement with the Gavi alliance, to provide a safe vaccine against Covid-19, through the COVAX mechanism, to which 80 countries adhere, including the countries of the European Union." , said Manastirliu.
Sources: Euronews, Guardian, European Commission, A2CNN, Ministry of Health and Social Protection
